Similarly, α-MG was shown to attenuate brain inflammation induced by peripheral lipopolysaccharide administration in C57BL/6J mice by reducing the levels of the proinflammatory cytokine IL-6, cyclooxygenase-2 (COX-2), and the 18 kDa translocator protein (TSPO)28. The gene discussed is TSPO; the disease is brain inflammatory disease.